New ventures
We support researchers to build cancer-focused startups and spin-outs and secure investment through our extensive network.
Our startups
We have built an incredible production line for startup companies to bring early-stage technologies out of the research lab and translate them into patient benefit. Our startup portfolio secures funding from investors around the world who believe in our world class science and the power of partnership.
60+
we've formed 60+ startups across therapeutics, diagnostics and MedTech
£2.3bn+
over £2.3bn investment raised by our startup portfolio
17
17 startup exits to date
£822m
£822m investment raised by our startup portfolio in 2020/21
Active startups
Exited startups
Adaptate
![Adaptate logo]()
Case study
ADC Therapeutics
![ADC Therapeutics logo]()
Case study
GammaDelta Therapeutics
![Gamma Delta logo]()
Case study
KuDOS Pharmaceuticals
![Kudos pharmaceuticals logo]()
Case study
Related content
